Literature DB >> 26492519

The association between the HLA-G 14-bp insertion/deletion polymorphism and type 1 diabetes.

H P V Silva1, M A G Ururahy1, K S C Souza1, M B Loureiro1, Y M C Oliveira1, G H M Oliveira1, A D Luchessi1, K T C Carvalho1, J C O C Freitas1, E A Donadi2, R D C Hirata3, M G Almeida1, R F Arrais4, M H Hirata3, A A Rezende1.   

Abstract

Type 1 diabetes (T1D) is a multifactorial disease that has a strong genetic component. The HLA-G is a nonclassical HLA class I locus that is associated with immunomodulatory functions, including downregulation of innate and adaptive immune responses and induction of immune tolerance. However, there is currently limited information about the involvement of HLA-G in T1D susceptibility. This case-control study aims to investigate the T1D susceptibility association of alleles and genotypes of a widely investigated 14-bp insertion/deletion polymorphism in the HLA-G and to provide further evidence of the frequency distribution of class II HLA-DR-DQ-risk genotypes in T1D children and adolescents in the Brazilian population. The deletion allele and the homozygous deletion genotype are associated with susceptibility to T1D and the insertion allele and the heterozygous deletion/insertion genotype are associated with protection from T1D. We also confirm that genetic susceptibility to T1D is associated with the DRB1*03:01-DQA1*05:01-DQB1*02:01 and DRB1*04-DQA1*03:01-DQB1*03:02 haplotypes in Brazilian northeast region. The DR3-DQ2/DR4-DQ8 genotype conferred the highest detected risk for T1D. Our results identify a novel association of the 14-bp deletion allele and the homozygous deletion genotype with T1D development and provide additional evidence of the importance of HLA class II heterozygous DR3-DQ2/DR4-DQ8 genotype in T1D susceptibility.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26492519     DOI: 10.1038/gene.2015.45

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  58 in total

1.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

2.  Association between an HLA-G 14 bp insertion/deletion polymorphism and non-segmental vitiligo in the Korean population.

Authors:  K-H Jeong; S-K Kim; B-K Kang; J-H Chung; M-K Shin; M-H Lee
Journal:  Arch Dermatol Res       Date:  2014-03-18       Impact factor: 3.017

3.  Linkage disequilibrium between human leukocyte antigen (HLA) class II and HLA-G--possible implications for human reproduction and autoimmune disease.

Authors:  Thomas Vauvert F Hviid; Ole B Christiansen
Journal:  Hum Immunol       Date:  2005-06       Impact factor: 2.850

4.  The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients.

Authors:  Tal Twito; Jemy Joseph; Amelia Mociornita; Vivek Rao; Heather Ross; Diego H Delgado
Journal:  J Heart Lung Transplant       Date:  2011-04-08       Impact factor: 10.247

Review 5.  [Distribution and frequency of HLA alleles and haplotypes in Brazilians with type 1 diabetes mellitus].

Authors:  Crésio Alves; Isadora Meyer; Nara Vieira; Maria Betânia P Toralles; Denise LeMaire
Journal:  Arq Bras Endocrinol Metabol       Date:  2006-06

6.  Soluble human leukocyte antigen-g expression and glucose tolerance in subjects with different degrees of adiposity.

Authors:  Anna Solini; Elza Muscelli; Marina Stignani; Loredana Melchiorri; Eleonora Santini; Chiara Rossi; Brenno Domingues Astiarraga; Roberta Rizzo; Olavio Roberto Baricordi
Journal:  J Clin Endocrinol Metab       Date:  2010-04-28       Impact factor: 5.958

7.  HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.

Authors:  R Rizzo; T V F Hviid; M Govoni; M Padovan; M Rubini; L Melchiorri; M Stignani; S Carturan; M T Grappa; M Fotinidi; S Ferretti; A Voss; H Laustrup; P Junker; F Trotta; O R Baricordi
Journal:  Tissue Antigens       Date:  2008-03-29

8.  Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.

Authors:  S Caillat-Zucman; H J Garchon; J Timsit; R Assan; C Boitard; I Djilali-Saiah; P Bougnères; J F Bach
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

9.  Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease.

Authors:  M K Misra; S Prakash; R Kapoor; S K Pandey; R K Sharma; S Agrawal
Journal:  Tissue Antigens       Date:  2013-11

10.  Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A.

Authors:  Sergey Nejentsev; Joanna M M Howson; Neil M Walker; Jeffrey Szeszko; Sarah F Field; Helen E Stevens; Pamela Reynolds; Matthew Hardy; Erna King; Jennifer Masters; John Hulme; Lisa M Maier; Deborah Smyth; Rebecca Bailey; Jason D Cooper; Gloria Ribas; R Duncan Campbell; David G Clayton; John A Todd
Journal:  Nature       Date:  2007-11-14       Impact factor: 49.962

View more
  6 in total

1.  Combined effect of glutamine at position 70 of HLA-DRB1 and alanine at position 57 of HLA-DQB1 in type 1 diabetes: An epitope analysis.

Authors:  Petroula Gerasimou; Vicky Nicolaidou; Nicos Skordis; Michalis Picolos; Demetrios Monos; Paul A Costeas
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

2.  "HLA-G 3'UTR gene polymorphisms and rheumatic heart disease: a familial study among South Indian population".

Authors:  Maheshkumar Poomarimuthu; Sivakumar Elango; Sambath Soundrapandian; Jayalakshmi Mariakuttikan
Journal:  Pediatr Rheumatol Online J       Date:  2017-02-01       Impact factor: 3.054

3.  Altered Frequency and Phenotype of HLA-G-Expressing DC-10 in Type 1 Diabetes Patients at Onset and in Subjects at Risk to Develop the Disease.

Authors:  Giada Amodio; Alessandra Mandelli; Rosalia Curto; Paola M V Rancoita; Angela Stabilini; Riccardo Bonfanti; Maurizio de Pellegrin; Emanuele Bosi; Clelia Di Serio; Manuela Battaglia; Silvia Gregori
Journal:  Front Immunol       Date:  2021-10-01       Impact factor: 7.561

Review 4.  Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population.

Authors:  Iman Akhlaghipour; Amir Reza Bina; Mohammad Reza Mogharrabi; Ali Fanoodi; Amir Reza Ebrahimian; Soroush Khojasteh Kaffash; Atefeh Babazadeh Baghan; Mohammad Erfan Khorashadizadeh; Negin Taghehchian; Meysam Moghbeli
Journal:  Hum Genomics       Date:  2022-04-02       Impact factor: 4.639

Review 5.  HLA-G Genotype/Expression/Disease Association Studies: Success, Hurdles, and Perspectives.

Authors:  Giada Amodio; Silvia Gregori
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

Review 6.  The HLA-G Immune Checkpoint Plays a Pivotal Role in the Regulation of Immune Response in Autoimmune Diseases.

Authors:  Monika Zaborek-Łyczba; Jakub Łyczba; Paulina Mertowska; Sebastian Mertowski; Anna Hymos; Martyna Podgajna; Paulina Niedźwiedzka-Rystwej; Ewelina Grywalska
Journal:  Int J Mol Sci       Date:  2021-12-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.